Collegium Pharmaceutical, Inc.
COLLNASDAQHealthcare● Active
$33.58
+$0.20(+0.60%)
Market Cap$1.1B
P/E Ratio—
52W High$50.787
52W Low$29.08
Collegium Pharmaceutical, Inc.（COLL）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · COLL · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.78B | $0.63B | $0.57B | $0.46B | $0.28B |
| Cost of Revenue | $0.32B | $0.25B | $0.24B | $0.25B | $0.13B |
| Gross Profit | $0.46B | $0.38B | $0.33B | $0.21B | $0.15B |
| Gross Margin %(computed) | 59.35% | 59.76% | 57.55% | 45.15% | 54.40% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.01B |
| G&A Expenses | $0.00B | $0.17B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.28B | $0.21B | $0.16B | $0.18B | $0.13B |
| Operating Income | $0.19B | $0.17B | $0.17B | $0.03B | $0.02B |
| Operating Margin %(computed) | 23.97% | 26.91% | 29.46% | 7.18% | 6.37% |
| Interest Income | $0.01B | $0.01B | $0.02B | $0.00B | $0.00B |
| Interest Expense | $0.08B | $0.07B | $0.08B | $0.06B | $0.02B |
| Income Before Tax | $0.09B | $0.10B | $0.08B | ($0.03B) | ($0.00B) |
| Income Tax Expense | $0.03B | $0.03B | $0.03B | ($0.00B) | ($0.07B) |
| Net Income | $0.06B | $0.07B | $0.05B | ($0.03B) | $0.07B |
| Net Margin %(computed) | 8.05% | 10.96% | 8.50% | -5.39% | 25.83% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.98 | $2.14 | $1.60 | $-0.74 | $2.05 |
| Wtd Avg Shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| EBITDA | $0.40B | $0.34B | $0.31B | $0.17B | $0.09B |
| EBITDA Margin %(computed) | 51.37% | 54.11% | 54.40% | 37.36% | 31.26% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Collegium Pharmaceutical, Inc.
关于Collegium Pharmaceutical, Inc.（COLL）损益表
Collegium Pharmaceutical, Inc.（COLL）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，COLL实现营收$0.78B，毛利润$0.46B（毛利率59.35%），净利润$0.06B（净利率8.05%）。
常见问题
COLL · 4 问Collegium Pharmaceutical, Inc.（COLL）2025财年营收为$0.78B，同比up23.6%。
COLL revenueCOLL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08